Expertise in
5
conditions

Jean-philippe Coindre

Le Mans, FR 
Expertise in
5
conditions
Le Mans, FR 

Overview

Jean-philippe Coindre practices practicing medicine in Le Mans, France.

Mr. Coindre is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Le Mans, France
Other Locations
Laval, France
Cholet, France
Paris, France
CHU de Bordeaux
Bordeaux, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 20, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Enrollment Status: Completed
Publish Date: December 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

22 Total Publications

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.
Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.
Journal: Blood advances
Published: July 01, 2025

Frequently Asked Questions about Jean-philippe Coindre

Is Jean-philippe Coindre a top-rated expert for Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-philippe Coindre is classified as an Advanced expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-philippe Coindre participate in research or clinical trials?

Yes. Jean-philippe Coindre has published 22 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Jean-philippe Coindre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Coindre's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile